DETAILED NOTES ON FLUBROMAZEPAM

Ro4938581 is a nootropic drug invented in 2009 by a staff working for Hoffmann-La Roche, which acts being a subtype-selective inverse agonist for the α5 subtype of your benzodiazepine binding site about the GABAA receptor. It's got great selectivity to the α5 subtype and did not make convulsant or anxiogenic consequences in animal studies, which